BDP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.080650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.582200E-01
Normal-vs-Stage2
8.903700E-02
Normal-vs-Stage3
1.495780E-01
Normal-vs-Stage4
6.957800E-01
Stage1-vs-Stage2
1.156390E-01
Stage1-vs-Stage3
5.122900E-03
Stage1-vs-Stage4
9.423600E-01
Stage2-vs-Stage3
4.222200E-02
Stage2-vs-Stage4
2.294800E-01
Stage3-vs-Stage4
2.209800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.177000E-01
Normal-vs-AfricanAmerican
3.926200E-01
Normal-vs-Asian
3.736100E-02
Caucasian-vs-AfricanAmerican
8.798000E-01
Caucasian-vs-Asian
4.830000E-02
AfricanAmerican-vs-Asian
2.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.107600E-01
Normal-vs-Female
1.263580E-01
Male-vs-Female
8.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.326800E-01
Normal-vs-Age(41-60Yrs)
2.989400E-01
Normal-vs-Age(61-80Yrs)
6.594100E-02
Normal-vs-Age(81-100Yrs)
5.864000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.880800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.917600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.160400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.395970E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.838000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.860000E-02
Normal-vs-Daily Drinker
9.449800E-02
Normal-vs-Weekly Drinker
1.197170E-01
Normal-vs-Occasional Drinker
1.676850E-01
Normal-vs-Social Drinker
3.594800E-01
Non Drinker-vs-Daily Drinker
6.929200E-01
Non Drinker-vs-Weekly Drinker
9.538600E-01
Non Drinker-vs-Occasional Drinker
1.790450E-01
Non Drinker-vs-Social Drinker
1.422200E-01
Daily Drinker-vs-Weekly Drinker
7.335200E-01
Daily Drinker-vs-Occasional Drinker
3.979400E-01
Daily Drinker-vs-Social Drinker
3.115400E-01
Weekly Drinker-vs-Occasional Drinker
2.939400E-01
Weekly Drinker-vs-Social Drinker
2.655000E-01
Occasional Drinker-vs-Social Drinker
7.508200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.938400E-02
Normal-vs-Grade 2
1.156490E-02
Normal-vs-Grade 3
5.704900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.272800E-01
Grade 1-vs-Grade 3
8.412200E-01
Grade 1-vs-Grade 4
7.938400E-02
Grade 2-vs-Grade 3
4.881200E-01
Grade 2-vs-Grade 4
1.156490E-02
Grade 3-vs-Grade 4
5.704900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.588100E-02
Normal-vs-NonDiabetic
6.027500E-02
Diabetic-vs-NonDiabetic
8.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.265600E-02
Normal-vs-NoPancreatitis
7.216300E-02
Pancreatitis-vs-NoPancreatitis
1.954370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.909640E-01
Normal-vs-N1
8.749600E-02
N0-vs-N1
8.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.944380E-01
Normal-vs-TP53-NonMutant
4.227400E-01
TP53-Mutant-vs-TP53-NonMutant
2.696400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
